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OBJECTIVE—Conditional gene targeting has been extensively
used for in vivo analysis of gene function in -cell biology. The
objective of this study was to examine whether mouse transgenic
Cre lines, used to mediate -cell– or pancreas-speciﬁc recombi-
nation, also drive Cre expression in the brain.
RESEARCH DESIGN AND METHODS—Transgenic Cre lines
driven by Ins1, Ins2, and Pdx1 promoters were bred to R26R
reporter strains. Cre activity was assessed by -galactosidase
or yellow ﬂuorescent protein expression in the pancreas and
the brain. Endogenous Pdx1 gene expression was monitored
using Pdx1
tm1Cvw lacZ knock-in mice. Cre expression in
-cells and co-localization of Cre activity with orexin-express-
ing and leptin-responsive neurons within the brain was as-
sessed by immunohistochemistry.
RESULTS—All transgenic Cre lines examined that used the Ins2
promoter to drive Cre expression showed widespread Cre activ-
ity in the brain, whereas Cre lines that used Pdx1 promoter
fragments showed more restricted Cre activity primarily within
the hypothalamus. Immunohistochemical analysis of the hypo-
thalamus from Tg(Pdx1-cre)
89.1Dam mice revealed Cre activity in
neurons expressing orexin and in neurons activated by leptin.
Tg(Ins1-Cre/ERT)
1Lphi mice were the only line that lacked Cre
activity in the brain.
CONCLUSIONS—Cre-mediated gene manipulation using trans-
genic lines that express Cre under the control of the Ins2 and
Pdx1 promoters are likely to alter gene expression in nutrient-
sensing neurons. Therefore, data arising from the use of these
transgenic Cre lines must be interpreted carefully to assess
whether the resultant phenotype is solely attributable to alter-
ations in the islet -cells. Diabetes 59:3090–3098, 2010
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n vivo analysis of gene function in the pancreas and
-cells has beneﬁted from the development of
mouse lines expressing Cre in all pancreatic com-
partments or restricted to the islet -cells. The
choice of promoter to drive recombinase expression is
critical for controlling the location and timing of gene
activity. In addition, inducible versions of Cre recombi-
nase, e.g., CreER, allow temporal control to the manipu-
lation of gene activity, which becomes important when
analyzing gene function at speciﬁc embryonic and adult
stages (1,2). Promoters of the pancreas duodenal ho-
meobox 1 (Pdx1) (3,4) and insulin (Ins1 and Ins2) (5–8)
genes have been well characterized to allow the use of
regulatory sequences for directing Cre expression to spe-
ciﬁc pancreatic cell populations. Commonly used trans-
genic mouse lines that employ rat Ins2 gene promoter
sequences to drive Cre expression within the -cell popu-
lation include Ins2-Cre/RIP-Cre [Mouse Genome Infor-
matics (MGI): Tg(Ins2-cre)
25Mgn and Tg(Ins2-cre)
1Herr]
(9–11) and RIP-CreER [MGI: Tg(Ins2-cre/Esr1)
1Dam] (12).
Pdx1 gene promoter sequences have proven useful for
directing Cre expression throughout the early pancreatic
epithelium (4,10,13,14) and to the endocrine cells of the
pancreas (15). The Pdx1 gene is expressed early in pan-
creas development throughout the endoderm of the dorsal
and ventral buds, but expression becomes restricted dur-
ing development such that high levels of Pdx1 are main-
tained in the insulin-producing -cells with lower levels
in subpopulations of acinar cells (8,16). Examples of
Pdx1-Cre transgenic lines include Pdx1-Cre
early [MGI:
Tg(Pdx1-cre)
89.1Dam] (13), Pdx1-Cre
late [MGI: Tg(Ipf1-cre/
Esr1)
1Dam/Mmcd] (10), Pdx1-Cre [MGI: Tg(Ipf1-cre)
1Tuv]
(14), and Pdx1-CreER [MGI: Tg(Pdx1-cre/ERT)
1Mga] (15).
To assess the speciﬁcity of recombination and perform
lineage tracing analysis, reporter lines such as the
ROSA26-stop-lacZ [MGI: Gt(ROSA)26Sor
tm1Sho], also
known as R26R (17), or the ROSA26-stop-YFP [MGI:
Gt(ROSA)26Sor
tm1(EYFP)Cos] (18) mice have been devel-
oped. Upon Cre-mediated recombination, these reporter
lines activate expression of a -galactosidase (-gal) or a
yellow ﬂuorescent protein (YFP) reporter under the con-
trol of the ubiquitously active ROSA26 promoter, resulting
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regardless of their differentiation fate.
Here we show that most Cre lines currently being used
to mediate pancreas or -cell recombination also direct
Cre expression to areas of the brain, and this may lead to
altered gene expression in nutrient-sensing neurons that
affects nutrient homeostasis.
RESEARCH DESIGN AND METHODS
Mouse models. Transgenic Cre and R26R reporter mouse lines used in this
study are listed in Table 1. Experimental animals were generated by crossing
Tg(Ins2-cre)
25Mgn (termed RIP-Cre
Mgn) (11), Tg(Ins2-cre)
1Herr (termed RIP-
Cre
Herr) (10), Tg(Ins2-creEsr1)
1Dam (termed RIP-Cre/ERT) (12), Tg(Pdx1-
cre)
89.1Dam (termed Pdx1-Cre
Dam) (13), Tg(Ipf1-cre)
1Tuv (termed Pdx1-
Cre
Tuv) (14), Tg(Pdx1-cre/ERT)
1Mga (termed Pdx1
AI-III-Cre/ERT) (15), or
Tg(Ins1-cre/ERT)
1Lphi (termed MIP-Cre/ERT) (Tamarina et al., unpublished
data) transgenic lines with a reporter strain expressing either lacZ
Gt(ROSA)26Sor
tm1Sor (termed R26R
wt/lacZ) (17,19) or enhanced YFP
Gt(ROSA)26Sor
tm1(EYFP)Cos (termed R26R
wt/YFP) (18). Both R26R reporter
strains on C57BL/6 background were obtained from Jackson Laboratories
(Bar Harbor, ME). Pdx1
tm1Cvw mice (16) on B6D2 F1 background were
obtained from Dr. C.V. Wright (Vanderbilt University). Complete details of the
sources for all mouse strains used in this study are listed in supplementary
Table 1 (available at http://diabetes.diabetesjournals.org/cgi/content/full/db10-
0624/DC1). For timed pregnancies, noon on the day of the vaginal plug was
considered embryonic day 0.5 (e0.5). All animal studies were approved by the
Institutional Animal Care and Use Committees at the relevant institutions.
Reagents. Primary antibodies included guinea pig anti-porcine insulin IgG
(1:500; Dako, Carpinteria, CA), guinea pig anti-insulin antibody (1:1,000;
Millipore, Billerica, MA), rabbit anti–-gal IgG (1:5,000; MP Biomedicals,
Solon, OH), goat anti–-gal IgG (1:1,000; Biogenesis Ltd, Poole, UK), rabbit
anti-STAT3 phosphorylation (pSTAT3) IgG (1:1,000; Cell Signaling Technolo-
gies, Beverly, MA), rabbit anti-orexin IgG (1:2,000; Calbiochem, EMD Bio-
sciences/Merck, Darmstadt, Germany), and rabbit anti-Cre antibody (1:1,000,
cat. #69050; EMD Biosciences, San Diego, CA). Fluorescent-labeled secondary
antibodies were purchased from Jackson ImmunoResearch (West Grove, PA)
and Invitrogen (Carlsbad, CA). Recombinant mouse leptin was obtained from
the National Hormone and Peptide Program (Los Angeles, CA).
Tamoxifen administration. Over a 5-day period, mice were injected subcu-
taneously or intraperitoneally with 3 doses of 1–8 mg tamoxifen (Sigma,
T5648) freshly dissolved in corn oil (Sigma, C8267) at 10 mg/ml, 20 mg/ml, or
corn oil vehicle. The subcutaneous injection site was sealed with a drop of
Vetbond tissue adhesive (3M). Following tamoxifen administration, the mice
were housed individually for 5–10 days before being analyzed for Cre-
recombinase–mediated activity.
Detection of -gal activity. -Gal activity was detected by 5-bromo-4-
chloro-3-indolyl--D-galactopyranoside (X-gal) staining as described previ-
ously (20) with slight modiﬁcations. Brieﬂy, pancreata and brains were
dissected in ice-cold 10 mmol/l PBS and ﬁxed in freshly prepared 1–2%
paraformaldehyde for either 2–4 h at room temperature or overnight at 4°C.
Brains (2-mm slices) and pancreata were permeabilized for5hi n2mmol/l
MgCl2, 0.01% sodium deoxycholate, 0.02% NP-40, 10 mmol/l PBS, and then
stained overnight in the dark in 2 mmol/l MgCl2, 5 mmol/l potassium
ferricyanide, 5 mmol/l potassium ferrocyanide, 1 mg/ml X-gal, 0.01% sodium
deoxycholate, 0.02% NP-40, 10 mmol/l PBS pH 7.4 at ambient temperature or
37°C. Tissues were washed in PBS, postﬁxed in 4% paraformaldehyde for 1 h,
washed in PBS, and placed into 70% ethanol prior to whole mount imaging.
For YFP detection, embryos were dissected at e15.5 and imaged in whole
mount.
Leptin administration. Mice were injected intraperitoneally with leptin (5
mg/kg) or vehicle (PBS) and then rested for 2 h prior to perfusion.
Immunohistochemistry. Immunodetection of pancreatic Cre expression
was performed in 5-m parafﬁn sections prepared from paraformaldehyde-
ﬁxed pancreata of RIP-Cre
Mgn, RIP-Cre/ERT, Pdx1
AI-III-Cre/ERT, and MIP-
Cre/ERT mice. Transgenic lines expressing Cre/ERT received the third dose of
tamoxifen on the day prior to being killed. After antigen retrieval, sections
were incubated with primary antibodies to Cre and insulin (Millipore). For
immunodetection of -gal expression in the brain, mice were perfusion-ﬁxed,
and brains were removed and postﬁxed overnight as described previously
(21). Following cryoprotection, brains were sectioned into 30-m coronal
slices, collected in four consecutive series, and stored at 20°C. Sections
were then incubated with primary antibodies to pSTAT3, -gal (Biogenesis),
or orexin overnight at 4°C. Immunolabeling was visualized with appropriate
ﬂuorescent-labeled secondary antibodies. Digital images were acquired by
confocal microscopy. One-way ANOVA analysis was used to compare the
percent of -cells that express Cre in the islets of the different transgenic lines.
Quantitative RT-PCR. Islets (22) and hypothalamus were isolated from
adult Tg(Pdx1-cre)
89.1Dam (13) mice and their controls. Total cellular RNA
was isolated using the RNAqueous Small Scale Phenol-Free Total RNA
isolation kit (Ambion, Austin, TX), and trace contaminating DNA was removed
with the TURBO DNA-free kit (Ambion). High-quality RNA had a 28S–to–18S
ratio from 1.2 to 2.0 and an RNA integrity number from 8.2 to 8.9. Single-
stranded cDNA was generated by reverse transcription from 180-ng total RNA
using the Superscript III First Strand Synthesis kit (Invitrogen). cDNA (40
ng/reaction) was analyzed by quantitative RT-PCR using the ABI Prism 7900
Sequence Detection System and POWER SYBR Green Master Mix (Applied
Biosystems, Foster City, CA). Samples were analyzed in duplicates, and
TABLE 1
Mouse transgenic Cre and R26R reporter lines used in this study
MGI nomenclature
Synonym used in
this report
Institution using
this reporter
Transgene promoter
fragment or gene locus Original reference
Tg(Ins2-cre)
25Mgn RIP-Cre
Mgn Chicago Rat insulin 2–668 bp distal
to transcriptional start
(11)
Vanderbilt
Tg(Ins2-cre)
1Herr RIP-Cre
Herr Vanderbilt Rat insulin 2–660 bp from
transcriptional start
(10)
Tg(Ins2-creEsr1)
1Dam RIP-Cre/ERT Chicago Rat insulin 2–668 bp
fragment  hsp68
(12)
Tg(Ins1-cre/ERT)
1Lphi MIP-Cre/ERT Chicago Mouse insulin 1–8,500 bp
from transcriptional start
Tamarina et al. (in
preparation)
Tg(Pdx1-cre)
89.1Dam Pdx1-Cre
Dam Michigan Mouse Pdx1–5,500 bp from
transcriptional start
(13)
Vanderbilt
Tg(Ipf1-cre)
1Tuv Pdx1-Cre
Tuv Vanderbilt Mouse Pdx1–4,300 bp from
transcriptional start
(14)
Tg(Pdx1-cre/ERT)
1Mga Pdx1
AI-III-Cre/ERT Chicago Mouse Pdx1–1 kb fragment (15)
Vanderbilt (2 kb from
transcriptional start) 
hsp68 promoter
Pdx1
tm1Cvw Pdx1
wt/lacZ Vanderbilt Targeted inactivation (16)
Gt(ROSA)26Sor
tm1(EYFP)Cos R26R
YFP Vanderbilt Targeted insertion into the
Gt(ROSA)26Sor locus
(18)
Gt(ROSA)26Sor
tm1Sor R26R
lacZ Chicago Targeted insertion into the
Gt(ROSA)26Sor locus
(19)
Michigan
Vanderbilt
B. WICKSTEED AND ASSOCIATES
diabetes.diabetesjournals.org DIABETES, VOL. 59, DECEMBER 2010 3091relative cDNA levels were determined by comparing cycle threshold values of
Cre cDNA to Hypoxanthine phosphoribosyl transferase (HPRT) cDNA.
Samples with cycle threshold values greater than 40 were considered to have
undetectable amounts of template. Primer sequences were the following; Cre
(5TGCAACGAGTGATGAGGTTC3 and 5GCAAACGGACAGAAGCATTT3),
HPRT (5TACGAGGAGTCCTGTTGATGTTGC3 and 5GGGACGCAGCAA
CTGACATTTCTA3), and Pdx1 (5CTGAGGGACAAAGATGCAGA3 and
5TTCTAATTCAGGGCGTTGTG3). One-way ANOVA with Newman-Keuls
multiple comparison tests were used to compare outcomes in mice of different
genotypes. Data were expressed as mean  SE.
RESULTS
Using the R26R reporter line, the RIP-Cre
Mgn line (11) was
previously shown to have robust Cre-mediated recombi-
nation within the -cells and the ventral brain during
development (9). To investigate whether Cre-mediated
recombination occurred within the brain of other trans-
genic Cre lines using the rat Ins2 or Pdx1 promoter (Table
1), these mouse strains were crossed with the R26R
reporter strain and analyzed for -gal activity in whole
mount brain slices (Figs. 1 and 2). No X-gal staining was
detected in the brain or pancreas from control R26R
wt/lacZ
littermates indicating that -gal is not expressed in the
absence of Cre activity (Fig. 1B and F and supplementary
Fig. 1). In RIP-Cre
Mgn;R26R
wt/lacZ mice, widespread X-gal
staining was detected in most brain areas with robust
expression in the mid-brain and ventral regions, which
was consistent with previous reports (9) (Fig. 1C and
supplementary Fig. 2). In the brains of RIP-Cre
Herr;
R26R
wt/lacZ mice, X-gal staining was less widespread and
had a more punctate pattern without any obvious region-
alization (Fig. 1D and supplementary Fig. 3). The brains of
RIP-Cre/ERT;R26R
wt/lacZ mice with Cre activity induced
by three 2-mg doses of tamoxifen revealed a diffuse
intermediate pattern of X-gal staining that was more
extensive than in RIP-Cre
Herr;R26R
wt/lacZ mice but less
than in RIP-Cre
Mgn;R26R
wt/lacZ mice (Fig. 1E and supple-
mentary Fig. 4). All three transgenic lines, RIP-Cre
Mgn,
RIP-Cre
Herr, and RIP-Cre/ERT, showed a high level of
recombination in pancreatic islets (Fig. 1G–I and supple-
mentary Figs. 2–4).
Cre-mediated recombination within the brain of Pdx1-
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FIG. 1. RIP-Cre transgenic lines display Cre-mediated recombination in multiple regions of the brain. Adult brains were sliced into four or ﬁve coronal
sections and subjected to whole mount X-gal staining. Images of individual brain slices from each sectioning plane are available in supplementary Figs.
1–4. A: Sagittal and coronal views of mouse brain (adapted from Allen Mouse Brain Atlas, http://www.brain-map.org/) (29). A dashed vertical line marks
coronal sectioning plane spanning the hypothalamic region of the brain. B–E: Images of coronal brain slices located on the left side of the sectioning
plane in the sagittal view in A. B: R26R
wt/lacZ littermate control mice (n  17) lacked X-gal staining in the brain. The cortex (CTX) and hypothalamus
(HY) are labeled and correspond to regions marked on the coronal view in A. C: RIP-Cre
Mgn;R26R
wt/lacZ mice (n  8) showed X-gal staining throughout
the brain with high signal intensity in the mid-brain and ventral regions. D: RIP-Cre
Herr;R26R
wt/lacZ mice (n  14) showed weaker, punctate X-gal
staining throughout the brain without obvious regionalization. E: RIP-Cre/ERT;R26R
wt/lacZ mice (n  4) injected intraperitoneally with three 2-mg
doses of tamoxifen over a 5-day period displayed strong, punctate X-gal staining throughout the brain with expression pattern more restricted than in
RIP-Cre
Mgn; R26R
wt/lacZ mice. Brains from littermate controls injected with corn oil vehicle were negative for X-gal staining (data not shown). F–I:
Whole-mount X-gal staining of pancreas from R26R
wt/lacZ in F, RIP-Cre
Mgn; R26R
wt/lacZ in H, RIP-Cre
Herr;R26R
wt/lacZ in G, and RIP-Cre/ERT;R26R
wt/lacZ
mice in I. (A high-quality digital representation of this ﬁgure is available in the online issue.)
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FIG. 2. Pdx1-Cre transgenic lines show localized Cre-mediated recombination within speciﬁc regions of the brain including the hypothalamus.
Adult brains were sliced, labeled, and imaged as described in Fig. 1. Images of individual brain slices from each sectioning plane are available in
supplementary Figs. 5–7 and supplementary Fig. 9. A: Sagittal and coronal views of mouse brain. A dashed vertical line marks coronal sectioning
plane spanning hypothalamic region of the brain. B–D: Images of coronal brain slices located on the left side of sectioning plane in the sagittal
view in A. The schematics of the mouse brain are from the Allen Mouse Brain Atlas (http://www.brain-map.org/) (29). B: X-gal staining in
Pdx1-Cre
Dam;R26R
wt/lacZ brain (n  7) was localized to the brain stem and hypothalamus. C: X-gal positive cells in Pdx1-Cre
Tuv;R26R
wt/lacZ brain
(n  4) were localized to hypothalamic region. D: Adult Pdx1
AI-III-Cre/ERT;R26R
wt/lacZ mice (n  4) were injected subcutaneously with three 8-mg
doses of tamoxifen (right panel) and analyzed for lacZ expression. X-gal staining had a broader punctate pattern with high-intensity signal
localized to the hypothalamic region. Brains from littermate controls injected with corn oil vehicle (n  2) were negative for X-gal staining (data
not shown). E: Brains from adult Pdx1
lacZ/wt mice (n  4) were negative for X-gal staining. F–I: Whole-mount X-gal staining of pancreas from
Pdx1-Cre
Dam;R26R
wt/lacZ in F, Pdx1-Cre
Tuv;R26R
wt/lacZ in G, Pdx1
AI-III-Cre/ERT;R26R
wt/lacZ mice in H, and Pdx1
lacZ/wt mice in I. J and K: Brains
from Pdx1-Cre
Tuv;R26R
wt/lacZ embryos at e15.5 (n  6) in J were analyzed for LacZ expression. X-gal staining indicated expression of Pdx1-Cre
Tuv
transgene in the brain stem and ventral region of the brain that gives rise to the hypothalamus (arrows). Pancreas in K had expected X-gal
staining. Similar results were obtained using the R26R
YFP reporter strain in supplementary Fig. 8. Brain and pancreas from R26R
wt/lacZ (n  5)
and R26R
wt/YFP (n  6) e15.5 controls were negative for X-gal staining and YFP ﬂuorescence, respectively (supplementary Fig. 8). L and M: Brains
from e15.5 Pdx1
lacZ/wt embryos (n  7) in L were negative for X-gal staining, while pancreas showed expected X-gal positivity in M. In e15.5
Pdx1
wt/wt embryos (n  10), both brain and pancreas were X-gal negative (supplemental Fig. 9). CTX, cortex; D, duodenum; DP, dorsal pancreas;
HY, hypothalamus; IIIv, third ventricle; PH, posterior hypothalamic region; Sp, spleen; St, stomach; VP, ventral pancreas. (A high-quality digital
representation of this ﬁgure is available in the online issue.)
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recombination was reported in the pharyngeal region of
Pdx1-Cre
Dam;R26R
wt/lacZ embryos (23). Unlike the wide-
spread recombination in brains from RIP-Cre transgenic
lines, X-gal staining in Pdx1-Cre
Dam;R26R
wt/lacZ brains
(Fig. 2B and supplementary Fig. 5) and Pdx1-Cre
Tuv;
R26R
wt/lacZ brains (Fig. 2C and supplementary Fig. 6) was
localized primarily to the hypothalamus and brain stem.
Analysis of Cre mRNA by quantitative RT-PCR in the
Pdx1-Cre
Dam line conﬁrmed expression in the hypothala-
mus with levels of hypothalamic expression 12.6-fold
lower than in islets (supplemental Fig. 5). Pdx1
AI-III-Cre/
ERT transgenic mice express the tamoxifen-inducible Cre
(15). Injection of a single dose of tamoxifen into pregnant
females (2 mg/40 g body weight) at e16.5 did not result in
recombination in the brains of Pdx1
AI-III-Cre/ERT;R26R
wt/lacZ
embryos dissected at e20.5 (15). In adult Pdx1
AI-III-Cre/
ERT;R26R
wt/lacZ mice injected with three 1-mg doses of
tamoxifen, recombination was detected mainly in the
hypothalamus (supplementary Fig. 7, left panel). However,
three 8-mg doses of tamoxifen induced much broader
recombination throughout the brain, suggesting that the
extent of recombination in the adult brain is dependent
upon the tamoxifen dose (Fig. 2D and supplementary Fig.
7, right panel). These data suggest that the Pdx1
AI-III-Cre/
ERT transgene is expressed in the adult brain but not in
the e16.5 brain, although it is possible that higher tamox-
ifen levels may be needed to induce Cre-mediated recom-
bination within the embryonic brain.
To further examine the timing of Cre expression in the
brains of the Pdx1-Cre lines expressing constitutively
active Cre, we studied the Pdx1-Cre
Tuv transgenic line
crossed into either R26R
lacZ/lacZ or R26R
YFP/YFP reporter
mice and analyzed embryos at e15.5 (Fig. 2J–K and
supplementary Fig. 8). Both reporter strains demonstrated
Cre activity in the brain stem and ventral region of the
developing brain that gives rise to the hypothalamus,
indicating that functional Cre protein is expressed in the
ventral region of the Pdx1-Cre
Tuv brain prior to e15.5.
To determine whether Cre activity in the hypothalamus
of the three different Pdx1-Cre transgenes was due to
previously unrecognized endogenous Pdx1 expression, a
mouse line with a lacZ reporter cassette in the Pdx1 locus
was examined (16). Both adult and embryonic (e15.5)
Pdx1
wt/lacZ (Fig. 2E and L and supplementary Fig. 9) brains
were negative for X-gal staining. Furthermore, expression
of the endogenous Pdx1 gene was undetectable in the
hypothalamus by real-time RT-PCR (data not shown)
indicating that Pdx1-Cre
Dam, Pdx1-Cre
Tuv, and Pdx1
AI-III-
Cre/ERT transgenes are ectopically expressed in the brain.
Detection of Cre-mediated recombination in the hypo-
thalamus of Pdx1-Cre
Dam;R26R
wt/lacZ mice (Fig. 2B, sup-
plementary Fig. 5, and supplementary Fig. 10) raised the
possibility that Cre protein may be expressed in neurons
involved in the regulation of energy and glucose homeosta-
sis. To determine the extent of Cre-mediated recombina-
tion within these speciﬁc neuronal populations, -gal
positive cells in brain sections from leptin-treated Pdx1-
Cre
Dam;R26R
wt/lacZ mice were co-localized with orexin
and leptin-induced pSTAT3, respectively. In the lateral
hypothalamus, -gal protein was expressed in a complex
pattern that partially overlapped with both the orexin-
expressing and LepRb-expressing neuronal populations
(Fig. 3), although signiﬁcant populations of -gal positive
cells did not overlap with the neuronal cell population in
either the lateral hypothalamus or in other hypothalamic
regions including the arcuate nucleus. Nonetheless, these
data clearly illustrate that the Pdx1-Cre
Dam line induces
Cre-mediated recombination in subpopulations of hypo-
thalamic neurons involved in energy expenditure and
glucose metabolism.
A new transgenic line, MIP-Cre/ERT, which employs an
8.5-kb fragment of the mouse Ins1 promoter has been
recently developed to express the tamoxifen-inducible
Cre/ERT in -cells (Tamarina et al., unpublished data)
(Table 1). Following three doses of 2-mg tamoxifen, strong
-gal activity was detected in the pancreatic islets of adult
MIP-Cre/ERT;R26R
wt/lacZ mice but not in their R26R
wt/lacZ
littermates (Fig. 4). By contrast, no -gal activity was
detected in any region of the brain from MIP-Cre/ERT;
R26R
wt/lacZ mice (Fig. 4). Furthermore, when the tamox-
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FIG. 3. Pdx1-Cre
Dam;R26R
wt/lacZ mice display a complex pattern of
Cre-mediated recombination that partially overlaps with orexin-posi-
tive and leptin-responsive neuronal populations. Adult Pdx1-Cre
Dam;
R26R
wt/lacZ mice were treated with leptin (5 mg/kg, intraperitoneally,
2 h), perfusion-ﬁxed and brains isolated for immunohistochemical
detection of pSTAT3, orexin, and -gal positive. Localization of -gal
signal in brain sections of adult Pdx1-Cre
Dam;R26R
wt/lacZ mice is
available in supplementary Fig. 10. A–C: pSTAT3 (green) and -gal
(red) immunoreactivity do not co-localize efﬁciently in the arcuate
nucleus (ARC). D–I: Co-localization of pSTAT3 (green) and -gal (red)
immunoreactivity in a subpopulation of neurons in the lateral hypo-
thalamus (LHA). Despite extensive -gal labeling within the preoptic
area, there was essentially no co-localization with leptin-responsive
neurons (data not shown). J–O: Co-localization of orexin (green) and
-gal (red) immunoreactivity within neurons in the LHA. Arrows
indicate co-labeled neurons. All scale bars are either 50 m or 200 m
(as indicated). The unlabeled scale bar in the ARC panel in A is 50 m.
(A high-quality digital representation of this ﬁgure is available in the
online issue.)
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FIG. 4. Cre activity is undetectable in MIP-Cre/ERT brain. Mice were injected intraperitoneally with three 2-mg doses of tamoxifen over a 5-day
period. Brains from adult MIP-Cre/ERT; R26R
wt/lacZ (n  5) and their R26R
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cortex; HY, hypothalamus. (A high-quality digital representation of this ﬁgure is available in the online issue.)
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activity was not detected within the brain (data not
shown). Cre expression efﬁciency in the -cells, as deter-
mined by immunohistochemistry, was similar in MIP-Cre/
ERT (89.0  8.0%), RIP-Cre (85.4  5.5%), RIP-Cre/ERT
(88.9  5.8%), and Pdx1-Cre/ERT (92.1  6.6%) mice
(supplemental Fig. 11).
DISCUSSION
The studies examining the in vivo role of genes associated
with biological processes in the pancreas and -cells have
relied largely upon fragments of the rat Ins2 gene pro-
moter or the Pdx1 gene promoter (3,8–13,16). Although
insulin secretion from -cells plays an important role in
glucose control, many other tissues including the brain are
intimately involved in the regulation of glucose metabo-
lism. Previous studies have demonstrated that the 668 bp
rat Ins2 promoter fragment drives Cre-recombinase ex-
pression within the central nervous system of the mouse
transgenic line, RIP-Cre
Mgn [Tg(Ins2-cre)
25Mgn] (9,24,25).
In this study, we examined whether Cre-mediated recom-
bination occurred in the brain of six mouse transgenic
lines that have been extensively used to express Cre
speciﬁcally within the pancreas or islet -cells (Table 1).
Analysis of Cre-mediated recombination using the R26R
reporter strain demonstrated that all six transgenic lines
expressed Cre recombinase to varying extents within the
brain, raising the possibility that alterations of gene ex-
pression in the brain may complicate the analysis and that
the observed phenotype may not be solely due to changes
in the -cell. This possibility was highlighted by a recent
study that used the RIP-Cre
Mgn line to selectively delete
the Stat3 gene in the -cells (24). STAT3-deﬁcient mice
displayed increased food intake, obesity, and leptin resis-
tance; physiological effects that the authors attributed to
STAT3 deﬁciency in the brain leading to impaired leptin
signaling.
There are no previous studies reporting Cre-mediated
recombination in the brain with Pdx1-Cre lines. Our
ﬁndings indicate that the Pdx1-Cre
Dam line causes recom-
bination in a subset of hypothalamic neurons involved in
energy and nutrient homeostasis. The similarity of -gal–
expression patterns in the hypothalamus with the other
two Pdx1-Cre transgenic lines suggest that Cre-mediated
recombination in these lines may also affect similar neu-
ronal subpopulations. The lack of -gal activity in the
brains of Pdx1
wt/lacZ mice indicates that the Cre expres-
sion in the brain of the Pdx1-Cre
Dam, Pdx1-Cre
Tuv, and
Pdx1
AI-III-Cre/ERT mice is not a reﬂection of endogenous
Pdx1 gene expression. A likely explanation for this spuri-
ous expression is the removal of these Pdx1 gene pro-
moter fragments from their endogenous gene context.
Furthermore, the similar recombination pattern generated
with Pdx1-Cre lines makes it unlikely that this brain
expression is a result of neighboring sequences at the sites
of integration, which are almost certainly different for
each line. While a lacZ knock-in reporter to analyze
endogenous Ins2 expression is currently not available, a
recent study demonstrated expression of the Ins2 gene
but not the Ins1 gene in the mouse hypothalamus (26).
Thus, in contrast to the inﬁdelity of Cre transgene expres-
sion found with the Pdx1 promoter, Cre expression ob-
served using the Ins2 promoter may reﬂect, in part,
endogenous promoter activity. It is not known whether the
ectopic expression of the insulin or Pdx-1 transgenes
occurs during the embryonic period, adult periods, or in
both periods.
Several caveats should be considered in interpreting our
results. First, we did not examine all currently available
insulin, PDX-1, or other gene promoters used to direct Cre
expression to the pancreas or -cell. Thus, it is essential
that investigators examine brain expression in any Cre line
thought to be pancreas- or -cell–speciﬁc. Second, our
results should not be interpreted to indicate speciﬁc
expression (or lack of expression) in any brain region or
nuclei as we did not perform detailed mapping of brain
regions following lacZ staining. We did note regions with
strong X-gal staining, but this should not be taken as
evidence that other areas do not express Cre, and it is
possible that a more isolated or diffuse expression in other
brain regions may also lead to Cre activity. More detailed
work is needed to identify which brain regions are positive
or negative for Cre activity. Third, whether Cre expression
leads to excision of a ﬂoxed DNA fragment is an incom-
pletely understood process that depends on both Cre
expression and the ﬂoxed allele. We mostly used a single
reporter line, and we do not know if the results would
differ with other lines that express other reporters such as
alkaline phosphatase. In fact, we predict that some
reporter lines will not show the same Cre activity we
observed given that a range of sensitivity of ﬂoxed
alleles to Cre-mediated recombination is likely (with the
R26R
wt/lacZ line being more Cre-sensitive) (27). This
possibility further complicates interpretation of studies
using Cre to inactivate a gene of interest. Thus, we urge
caution in extrapolating that the lack of Cre-mediated
recombination with a certain reporter gene predicts a lack
of Cre-mediated recombination of a gene of interest in the
brain. Based on the current study, it is clear that the
R26R
wt/lacZ ﬂoxed allele is susceptible to Cre-mediated
recombination in several brain regions, including orexin-
positive and leptin-responsive neuronal populations. Fi-
nally, the experimental intent for using Cre transgene must
be considered. If lineage tracing is the goal, is it preferable
to use a “sensitive” or “insensitive” reporter? If gene
inactivation is the goal of Cre-mediated recombination,
then whether other tissues or cells endogenously express
the gene of interest becomes a critical factor. If the gene of
interest is expressed in places other than the pancreas or
-cell (especially in the brain where a large number of
genes are known to be expressed in both tissues), then the
current ﬁnding of Cre-mediated recombination in brain
regions involved in glucose homeostasis, appetite, weight,
and energy expenditure make attributions of the pheno-
type to the -cell more difﬁcult.
The above analysis clearly illustrates that new trans-
genic lines are needed to ensure ﬁdelity of conditional Cre
expression in islet -cells. In transgenic Tg(Ins1-
EGFP)
1Hara mice (28), an 8.5-kb fragment of the mouse
Ins1 gene promoter was successfully used to express
enhanced green ﬂuorescent protein (eGFP) speciﬁcally
within islet -cells in the absence of eGFP expression in
other tissues. This same Ins1 promoter fragment was used
in the MIP-Cre/ERT transgenic line to direct Cre/ERT gene
expression in -cells (Tamarina et al., unpublished data).
The improved ﬁdelity of Cre expression observed in the
MIP-Cre/ERT line is likely due, in part, to the additional
regulatory elements within the larger promoter fragment
employed and because the mouse Ins1 gene is not ex-
pressed in the hypothalamus (26). Thus, the MIP-Cre/ERT
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efﬁciently and speciﬁcally in islet -cells.
In conclusion, this study reveals that the current trans-
genic lines utilizing Ins2 and Pdx1 promoter fragments
target Cre expression not only to the islet -cells, but also
to the brain. While not invalidating the use of these lines,
our data indicate that studies conducted using these Cre
transgenic mice should be interpreted carefully to assess
whether manipulation of the target gene within the brain
could contribute to the observed phenotype. The lack of
Cre-mediated recombination in the brain of MIP-Cre/ERT;
R26R
wt/lacZ mice suggests that the newly developed MIP-
Cre/ERT line is currently the only available -cell–speciﬁc
Cre line. As with all newly developed Cre transgenic lines,
caution must also be exhibited when using this line until
its potential as a -cell–speciﬁc Cre line has been validated
through further experimental analysis.
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